Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{-[(4,5)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate)
about
Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{-[(4,5)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate)
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Discovery of the Orally Effect ...... ihydrate (Rovatirelin Hydrate)
@en
Discovery of the Orally Effect ...... ihydrate (Rovatirelin Hydrate)
@nl
type
label
Discovery of the Orally Effect ...... ihydrate (Rovatirelin Hydrate)
@en
Discovery of the Orally Effect ...... ihydrate (Rovatirelin Hydrate)
@nl
prefLabel
Discovery of the Orally Effect ...... ihydrate (Rovatirelin Hydrate)
@en
Discovery of the Orally Effect ...... ihydrate (Rovatirelin Hydrate)
@nl
P2093
P2860
P356
P1433
P1476
Discovery of the Orally Effect ...... ihydrate (Rovatirelin Hydrate)
@en
P2093
Hiroshi Nakai
Katsuji Sugita
Katsumi Koike
Kouji Takahashi
Naotake Kobayashi
Norihito Sato
Takayoshi Yoshikawa
Tamio Sugawara
Tsuyoshi Kihara
Yukio Tada
P2860
P304
13647-13666
P356
10.1021/ACSOMEGA.8B01481
P407
P577
2018-10-31T00:00:00Z